{"id":"https://openalex.org/W4392698764","doi":"https://doi.org/10.1158/1535-7163.c.6539043.v1","title":"Data from Development of a Novel Antibody\u2013Drug Conjugate for the Potential Treatment of Ovarian, Lung, and Renal Cell Carcinoma Expressing TIM-1","display_name":"Data from Development of a Novel Antibody\u2013Drug Conjugate for the Potential Treatment of Ovarian, Lung, and Renal Cell Carcinoma Expressing TIM-1","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4392698764","doi":"https://doi.org/10.1158/1535-7163.c.6539043.v1"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.c.6539043.v1","doi":"https://doi.org/10.1158/1535-7163.c.6539043.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.c.6539043.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/1535-7163.c.6539043.v1","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074279762","display_name":"Lawrence J. Thomas","orcid":"https://orcid.org/0000-0002-5343-406X","observed_orcids":["https://orcid.org/0000-0002-5343-406X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lawrence J. Thomas","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043668012","display_name":"Laura A. Vitale","orcid":"https://orcid.org/0000-0003-2831-1794","observed_orcids":["https://orcid.org/0000-0003-2831-1794"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laura Vitale","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049640251","display_name":"Thomas J. O\u2019Neill","orcid":"https://orcid.org/0000-0003-2253-3118","observed_orcids":["https://orcid.org/0000-0003-2253-3118"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas O'Neill","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019473511","display_name":"Ree Y. Dolnick","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ree Y. Dolnick","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065404552","display_name":"Paul K. Wallace","orcid":"https://orcid.org/0000-0001-7823-9917","observed_orcids":["https://orcid.org/0000-0001-7823-9917"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul K. Wallace","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033083387","display_name":"Hans Minderman","orcid":"https://orcid.org/0000-0003-4987-9266","observed_orcids":["https://orcid.org/0000-0003-4987-9266"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hans Minderman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088479548","display_name":"Lauren E. Gergel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lauren E. Gergel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110331954","display_name":"Eric M. Forsberg","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eric M. Forsberg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067804761","display_name":"James M. Boyer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James M. Boyer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049410682","display_name":"James R. Storey","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James R. Storey","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025132756","display_name":"Catherine D. Pilsmaker","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Catherine D. Pilsmaker","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032022353","display_name":"Russell A. Hammond","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Russell A. Hammond","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057444634","display_name":"Jenifer Widger","orcid":"https://orcid.org/0000-0003-4691-7829","observed_orcids":["https://orcid.org/0000-0003-4691-7829"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jenifer Widger","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008025285","display_name":"Karuna Sundarapandiyan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Karuna Sundarapandiyan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079201987","display_name":"Andrea Crocker","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrea Crocker","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070126546","display_name":"Henry C. Marsh","orcid":"https://orcid.org/0000-0001-5637-6013","observed_orcids":["https://orcid.org/0000-0001-5637-6013"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Henry C. Marsh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5020755903","display_name":"Tibor Keler","orcid":"https://orcid.org/0000-0003-1757-4230","observed_orcids":["https://orcid.org/0000-0003-1757-4230"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tibor Keler","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12477","display_name":"Toxin Mechanisms and Immunotoxins","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tim-1","display_name":"TIM-1","score":0.8799999952316284},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.9860000014305115},{"id":"https://openalex.org/keywords/monomethyl-auristatin-e","display_name":"monomethyl auristatin E","score":0.9700000286102295},{"id":"https://openalex.org/keywords/renal-cell-carcinoma","display_name":"renal cell carcinoma","score":0.8659999966621399},{"id":"https://openalex.org/keywords/ovarian-adenocarcinoma","display_name":"ovarian adenocarcinoma","score":0.8920000195503235},{"id":"https://openalex.org/keywords/lung-cancer","display_name":"lung cancer","score":0.9710000157356262},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.734000027179718},{"id":"https://openalex.org/keywords/antibody-internalization","display_name":"antibody internalization","score":0.8519999980926514},{"id":"https://openalex.org/keywords/xenograft-antitumor-activity","display_name":"xenograft antitumor activity","score":0.8029999732971191},{"id":"https://openalex.org/keywords/targeted-cancer-therapy","display_name":"targeted cancer therapy","score":0.6480000019073486}],"concepts":[{"id":"https://openalex.org/C197336794","wikidata":"https://www.wikidata.org/wiki/Q5161150","display_name":"Conjugate","level":2,"score":0.6791583299636841},{"id":"https://openalex.org/C3019054536","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian carcinoma","level":4,"score":0.5682040452957153},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.5663160085678101},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5630196928977966},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.5596224069595337},{"id":"https://openalex.org/C2777546739","wikidata":"https://www.wikidata.org/wiki/Q33525","display_name":"Carcinoma","level":2,"score":0.5094800591468811},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.49032190442085266},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4656660556793213},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.43028855323791504},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.42225638031959534},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4192408621311188},{"id":"https://openalex.org/C2777325958","wikidata":"https://www.wikidata.org/wiki/Q1069596","display_name":"Antibody-drug conjugate","level":4,"score":0.41028547286987305},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38902077078819275},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.3274288475513458},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.28012609481811523},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.2777998447418213},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.24400252103805542},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.17498916387557983},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.06432738900184631},{"id":"https://openalex.org/C134306372","wikidata":"https://www.wikidata.org/wiki/Q7754","display_name":"Mathematical analysis","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1535-7163.c.6539043.v1","doi":"https://doi.org/10.1158/1535-7163.c.6539043.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.c.6539043.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.c.6539043.v1","doi":"https://doi.org/10.1158/1535-7163.c.6539043.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.c.6539043.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2409592001","https://openalex.org/W2131911545","https://openalex.org/W3174843013","https://openalex.org/W2796817351","https://openalex.org/W7171514931","https://openalex.org/W4249680282","https://openalex.org/W3041008693","https://openalex.org/W3081761416","https://openalex.org/W2891631057","https://openalex.org/W4282970098"],"abstract_inverted_index":{"Abstract":[0],"T-cell":[1],"immunoglobulin":[2],"and":[3,31,49,98,119,139,168,200,226,240],"mucin":[4],"domain":[5,84],"1":[6,22],"(TIM-1)":[7],"is":[8,38],"a":[9,62,74,102,184,211,223],"type":[10],"I":[11],"transmembrane":[12],"protein":[13,97],"that":[14],"was":[15,89,132,141,152,173],"originally":[16],"described":[17],"as":[18],"kidney":[19,30],"injury":[20],"molecule":[21],"(KIM-1)":[23],"due":[24],"to":[25,91,160,175,228],"its":[26],"elevated":[27],"expression":[28,37,56],"in":[29,41,47,57,137,177,210,218,236],"urine":[32],"after":[33],"renal":[34,48,111,237],"injury.":[35],"TIM-1":[36,99],"also":[39],"upregulated":[40],"several":[42],"human":[43,76],"cancers,":[44],"most":[45],"notably":[46],"ovarian":[50,117],"carcinomas,":[51],"but":[52,190],"has":[53,221],"very":[54],"restricted":[55],"healthy":[58],"tissues,":[59],"thus":[60],"representing":[61],"promising":[63],"target":[64],"for":[65,81],"antibody-mediated":[66],"therapy.":[67],"To":[68],"this":[69],"end,":[70],"we":[71],"have":[72],"developed":[73],"fully":[75],"monoclonal":[77],"IgG1":[78],"antibody":[79,88,131,157],"specific":[80],"the":[82,130,155,161,197,229],"extracellular":[83],"of":[85,104,186,231,234],"TIM-1.":[86],"This":[87],"shown":[90,174],"bind":[92],"purified":[93],"recombinant":[94],"chimeric":[95],"TIM-1-Fc":[96],"expressed":[100],"on":[101,192],"variety":[103,185],"transformed":[105],"cell":[106,113,188,194,238],"lines,":[107,189],"including":[108],"Caki-1":[109],"(human":[110,116,121],"clear":[112],"carcinoma),":[114],"IGROV-1":[115],"adenocarcinoma),":[118],"A549":[120,201],"lung":[122],"carcinoma).":[123],"Internalization":[124],"studies":[125,233],"using":[126],"confocal":[127],"microscopy":[128],"revealed":[129],"rapidly":[133],"internalized":[134],"by":[135,143],"cells":[136],"vitro,":[138],"internalization":[140],"confirmed":[142],"quantitative":[144],"imaging":[145],"flow":[146],"cytometry.":[147],"An":[148],"antibody\u2013drug":[149],"conjugate":[150],"(ADC)":[151],"produced":[153],"with":[154],"anti-TIM-1":[156],"covalently":[158],"linked":[159],"potent":[162],"cytotoxin,":[163],"monomethyl":[164],"auristatin":[165],"E":[166],"(MMAE),":[167],"designated":[169],"CDX-014.":[170],"The":[171],"ADC":[172],"exhibit":[176],"vitro":[178],"cytostatic":[179],"or":[180],"cytotoxic":[181],"activity":[182,209],"against":[183],"TIM-1\u2013expressing":[187,243],"not":[191],"TIM-1\u2013negative":[193],"lines.":[195],"Using":[196],"Caki-1,":[198],"IGROV-1,":[199],"xenograft":[202],"mouse":[203],"models,":[204],"CDX-014":[205,235],"showed":[206],"significant":[207],"antitumor":[208],"clinically":[212],"relevant":[213],"dose":[214],"range.":[215],"Safety":[216],"evaluation":[217],"nonhuman":[219],"primates":[220],"demonstrated":[222],"good":[224],"profile":[225],"led":[227],"initiation":[230],"clinical":[232],"carcinoma":[239],"potentially":[241],"other":[242],"tumors.":[244],"Mol":[245],"Cancer":[246],"Ther;":[247],"15(12);":[248],"2946\u201354.":[249],"\u00a92016":[250],"AACR.":[251]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2024-03-13T00:00:00"}